Search results for roche
Roche has approved extensive investment plans for its Penzberg, Mannheim and Kaiseraugst sites. Around 280 million Swiss francs will be invested in e
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Roche announced that it has entered into four new technology transfers with local manufacturing companies in Africa and Asia; Regal Pharmaceuticals i
read more »
Add this link to...
Bury
Add to:
| Bookmarks
The Roche Group posted record results in 2007. Group sales were up significantly, advancing 10% in local currencies (10% in Swiss francs; 15% in US d
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Nothing spices up a patent dispute like a little name-calling. So we were eager to read Amgen's filing today in its patent case against Roche, after we got a juicy tip from Dow Jones Newswires' Tho
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Roche's Annual General Meeting, which was held today in Basel, has approved all the Board of Directors' proposals. The 662 shareholders in attendance, representing 143,480,308, or 89.7% of a total
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Roche announced that it will acquire Piramed Limited, a privately-owned UK company focusing on therapeutics targeting PI3-kinase (PI3-K). The PI3-K pathway is known to play an important role in disea
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Roche announced that Actemra (tocilizumab) can significantly inhibit structura[1] damage to joints in patients with rheumatoid arthritis (RA), a critical measure of effectiveness of an RA treatment.
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Roche announced that its ownership stake in Chugai will increase from 50.1% to 59.9% following the successful completion of the tender offer which started on 23 May. Chugai shareholders had the oppor
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Roche announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) by a near unanimous (10-1) vote recommended approval of Actemra (tocilizumab), a novel interleukin
read more »
Add this link to...
Bury
Add to:
| Bookmarks